ICD-10-CM Billable Code

C44.11

Basal cell carcinoma of skin of eyelid, including canthus

Clinical Classification Guidelines

Medical Intelligence & Overview

Basal cell carcinoma (BCC) of the skin of the eyelid, classified under ICD-10 code C44.11, is a common form of skin cancer that develops in the basal cells located in the outermost layer of the skin. This type of cancer predominantly affects areas of the skin exposed to the sun, including the eyelids and canthus (the corner of the eye where the eyelids meet). Though BCC tends to grow slowly and rarely spreads to other parts of the body, early detection and treatment are crucial to prevent local tissue damage and preserve eye function.

Causes & Symptoms

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun Use of tanning beds or artificial UV light sources Older age, as the risk increases over time Fair skin complexion, which offers less protection against UV rays History of skin cancer or precancerous skin lesions Genetic predisposition or family history of skin cancers Immunosuppression or weakened immune system Exposure to certain chemicals or arsenic

Key Symptoms: A persistent skin growth that may be shiny or pearly in appearance A lesion that appears translucent, with visible blood vessels A small, waxy, or scar-like area on the eyelid or canthus An ulcerated sore that heals and then reopens Redness, swelling, or a sore that does not heal Possible crusting or bleeding from the lesion Changes in the appearance of the skin around the eyelid

Diagnostic & Treatment

Diagnosis Path: Diagnosis of basal cell carcinoma in the eyelid involves a combination of clinical examination and biopsy. During the physical exam, a healthcare professional assesses the lesion’s appearance and size. If BCC is suspected, a small tissue sample (biopsy) is taken and examined under a microscope to confirm the diagnosis and rule out other skin cancers. Imaging tests may be utilized if there is concern about deeper tissue involvement or spread beyond the eyelid.

Treatment Protocols: Treatment strategies for BCC of the eyelid aim to remove the carcinogenic tissue while preserving as much eye function and appearance as possible. Common treatment options include: - Surgical excision: The lesion is carefully cut out, often with a margin of healthy tissue. - Mohs micrographic surgery: A precise technique that allows examination of the tissue layer by layer during surgery to ensure complete removal. - Cryotherapy: Freezing the tumor with extreme cold to destroy cancer cells. - Topical treatments: Medications like imiquimod or 5-fluorouracil in select cases. - Radiation therapy: Used when surgery isn’t feasible or as an adjunct to surgical removal. Follow-up care is critical to monitor for recurrence or new lesions, especially in individuals at higher risk. Preventive measures include minimizing sun exposure, wearing protective eyewear, and regular skin checks by healthcare providers.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C44.11 a billable ICD-10 code?
Yes, C44.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C44.11?
Clinical documentation must specify the nature of Basal cell carcinoma of skin of eyelid, including canthus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference